1. Home
  2. Labeler Index
  3. Msd International Gmbh (singapore Branch)
  4. 75895-0136
  5. NDC Package Code: 75895-0136-0 Pembrolizumab

NDC Package 75895-0136-0 Pembrolizumab

Injection, Solution - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
75895-0136-0
Package Description:
179 VIAL in 1 TRAY / 4 mL in 1 VIAL
Product Code:
75895-0136
Non-Proprietary Name:
Pembrolizumab
Substance Name:
Pembrolizumab
Usage Information:
Pembrolizumab is used to treat cancer. It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies.
11-Digit NDC Billing Format:
75895013600
Product Type:
Drug For Further Processing
Labeler Name:
Msd International Gmbh (singapore Branch)
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s):
  • PEMBROLIZUMAB 25 mg/mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    01-15-2015
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 75895-0136-0?

    The NDC Packaged Code 75895-0136-0 is assigned to an UNFINISHED drug package of 179 vial in 1 tray / 4 ml in 1 vial of Pembrolizumab, drug for further processing labeled by Msd International Gmbh (singapore Branch). The product's dosage form is injection, solution and is administered via form.

    Is NDC 75895-0136 included in the NDC Directory?

    Yes, Pembrolizumab is an UNFINISHED PRODUCT with code 75895-0136 that is active and included in the NDC Directory. The product was first marketed by Msd International Gmbh (singapore Branch) on January 15, 2015 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 75895-0136-0?

    The 11-digit format is 75895013600. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-175895-0136-05-4-275895-0136-00